EU FMD: Uniform practice for all
In less than four months, by February 9, 2019 the Falsified Medicines Directive (FMD) will be implemented in more than 30…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Management
Pre-authorisation regulatory guidance for marketing of medicines in India
Rajdutt Shekhar Singh, Partner, Singh & Associates, shares insights on ways to effective marketing strategy
Pharma licensing framework and the way forward
Sanjay Sharma, Head-Lifesciences, NCF, UK; Ritu Hasija, Director Corporate and Girish Arora, Managing Director, Alniche…
Lupin’s Nagpur plant gears for future growth
During a recent plant visit to Lupin’s Nagpur facility, Swati Rana in an interaction with
Rajiv Desai, Executive VP - Corporate…
India adopts proactive approach in adopting biosimilars to bring down cost
Introduction of new drugs in the form of biosimilars will bring in new drug delivery system. The Indian pharma companies are…
Behind all the hype and hoopla about biosimilars
Looking at the pipeline of biosimilars, India shall remain a major market for biosimilars. Dr Siddharth Dutta, Associate Vice…
Good medicines come in quality packages
In the third of a series of six articles, Organisation of Pharmaceutical Producers of India (OPPI) launches the Know Your Pill…
Direct to consumer advertising of medicines and medical devices — a call for action!
Dr Milind Antani, Anay Shukla and Darren Punnen from Nishith Desai Associates, give an insight on the scope of laws that regulate…
Customer Voice – It means business!
Mohan G Joshi, International Business Coach and Former President, SCHOTT Glass India elaborates on unlocking the hitherto untapped…
Players in global cancer supportive care products market focus on getting approvals from governing…
Leading manufacturers are enhancing their business operations and encouraging R&D activities